Description
Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness, enabling patients to avail disease-modifying drugs and therapies and stay fit and healthy.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 22-Sep-2021 | 00.00 | Completed | Out of Business | ||
2. Early Stage VC (Series B1) | 27-Feb-2017 | 00.000 | 00.00 | 000.00 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 08-Jul-2015 | $1M | $1M | 000 | Completed | Generating Revenue |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-2 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series B-1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 1,000,000 | $0.001000 | 5% | $1 | $1 | 1x | $1 | 11.2% |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20160207893-A1 | Novel calcium modulators | Abandoned | 30-Dec-2014 | 0000000000 | |
JP-2018500382-A | New calcium regulator | Pending | 30-Dec-2014 | 0000000000 | |
EP-3240547-A4 | Novel calcium modulators | Withdrawn | 30-Dec-2014 | 0000000000 | |
EP-3240547-A1 | Novel calcium modulators | Withdrawn | 30-Dec-2014 | 0000000000 | |
CA-2971869-A1 | Novel calcium modulators | Abandoned | 30-Dec-2014 | C07D281/10 |